Explore the exciting world of Bristol Meyers Squibb (BMY -5.00%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
*Stock prices used were the prices of Jul. 9, 2025. The video was published on Jul. 30, 2025.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Bristol Myers Squibb: A Stock with Potential Amid Challenges
NYSE: BMY
Bristol Myers Squibb

Anand Chokkavelu, CFA has no position in any of the stocks mentioned. Karl Thiel has positions in Bristol Myers Squibb. Keith Speights has positions in Bristol Myers Squibb. The Motley Fool has positions in and recommends Bristol Myers Squibb. The Motley Fool has a disclosure policy.
Stocks Mentioned

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.